| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
18,764 |
16,027 |
$6.93M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
34,392 |
30,163 |
$5.74M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
178,054 |
155,995 |
$4.34M |
| J9271 |
Injection, pembrolizumab, 1 mg |
791 |
519 |
$4.16M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
29,725 |
27,178 |
$2.78M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
153,553 |
112,684 |
$2.72M |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
4,367 |
3,338 |
$2.04M |
| 80053 |
Comprehensive metabolic panel |
70,537 |
56,593 |
$1.96M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
8,112 |
7,283 |
$1.83M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
94,769 |
75,815 |
$1.80M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
25,541 |
18,857 |
$1.78M |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
30,281 |
21,332 |
$1.62M |
| 80048 |
Basic metabolic panel (calcium, ionized) |
67,667 |
51,729 |
$1.58M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
8,952 |
8,329 |
$1.53M |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
33,801 |
25,865 |
$1.51M |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
16,328 |
12,088 |
$1.50M |
| J1459 |
Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg |
1,870 |
893 |
$1.49M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
53,867 |
46,034 |
$1.41M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
12,100 |
6,617 |
$1.34M |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
27,388 |
20,938 |
$1.22M |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
73,224 |
58,228 |
$1.20M |
| G0378 |
Hospital observation service, per hour |
13,373 |
5,374 |
$1.08M |
| 84443 |
Thyroid stimulating hormone (TSH) |
41,086 |
36,681 |
$1.03M |
| J2505 |
Injection, pegfilgrastim, 6 mg |
456 |
305 |
$917K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
17,278 |
14,069 |
$910K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
4,370 |
3,932 |
$902K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
620 |
497 |
$898K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
9,683 |
7,977 |
$858K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
20,734 |
14,397 |
$833K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
11,631 |
10,205 |
$782K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
1,097 |
1,059 |
$766K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
491 |
378 |
$752K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
11,994 |
8,094 |
$751K |
| J0178 |
Injection, aflibercept, 1 mg |
1,131 |
896 |
$747K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
17,059 |
10,380 |
$746K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
20,939 |
17,507 |
$746K |
| 70450 |
Computed tomography, head or brain; without contrast material |
7,623 |
6,774 |
$722K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
19,210 |
16,471 |
$690K |
| 81001 |
|
41,446 |
35,563 |
$669K |
| 36430 |
|
1,519 |
792 |
$667K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
10,902 |
7,396 |
$636K |
| 86850 |
|
24,329 |
20,210 |
$619K |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
299 |
275 |
$602K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
2,140 |
1,783 |
$601K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
8,819 |
8,055 |
$585K |
| 85610 |
|
29,081 |
21,996 |
$573K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
7,656 |
4,800 |
$566K |
| 71045 |
Radiologic examination, chest; single view |
18,089 |
15,072 |
$556K |
| 83735 |
|
38,585 |
22,876 |
$549K |
| 77386 |
|
1,197 |
85 |
$544K |
| J0897 |
Injection, denosumab, 1 mg |
555 |
485 |
$540K |
| Q3014 |
Telehealth originating site facility fee |
23,401 |
20,876 |
$540K |
| 86900 |
|
24,027 |
19,871 |
$505K |
| 86901 |
|
23,989 |
19,839 |
$496K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
26,213 |
22,748 |
$492K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
4,083 |
3,234 |
$491K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
13,124 |
11,566 |
$486K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
13,107 |
11,551 |
$485K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
5,325 |
4,741 |
$483K |
| 84484 |
|
20,157 |
14,778 |
$475K |
| 71046 |
Radiologic examination, chest; 2 views |
13,979 |
12,681 |
$462K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
14,411 |
13,357 |
$451K |
| 85027 |
|
28,138 |
24,036 |
$444K |
| 82248 |
|
31,749 |
26,204 |
$439K |
| 96417 |
|
2,804 |
1,654 |
$432K |
| 85730 |
|
15,493 |
12,567 |
$430K |
| 93325 |
|
4,570 |
4,156 |
$427K |
| 82565 |
|
21,572 |
15,067 |
$416K |
| 84460 |
|
22,076 |
15,899 |
$413K |
| 84450 |
|
22,213 |
15,934 |
$402K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
24,693 |
22,717 |
$393K |
| 96367 |
|
6,013 |
3,563 |
$388K |
| 64615 |
|
2,736 |
2,062 |
$387K |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
9,926 |
5,761 |
$387K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
13,220 |
10,409 |
$377K |
| 95782 |
|
408 |
394 |
$368K |
| 80061 |
Lipid panel |
19,265 |
17,920 |
$366K |
| 82803 |
|
10,752 |
8,738 |
$365K |
| 84702 |
|
13,173 |
10,995 |
$356K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,415 |
13,201 |
$355K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
3,098 |
2,754 |
$354K |
| 92134 |
|
7,907 |
7,131 |
$354K |
| 95813 |
|
1,360 |
1,297 |
$353K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
7,794 |
4,200 |
$350K |
| 84100 |
|
29,202 |
17,163 |
$349K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
641 |
499 |
$345K |
| 83605 |
|
11,867 |
9,439 |
$344K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
2,025 |
1,814 |
$328K |
| 64493 |
|
945 |
700 |
$321K |
| 76770 |
|
4,950 |
4,624 |
$321K |
| 70496 |
|
1,508 |
1,357 |
$320K |
| 84075 |
|
15,017 |
9,805 |
$318K |
| J9299 |
Injection, nivolumab, 1 mg |
55 |
36 |
$314K |
| 92060 |
|
13,290 |
12,525 |
$299K |
| 96415 |
|
3,022 |
1,757 |
$297K |
| C1769 |
Guide wire |
3,347 |
2,783 |
$288K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
5,140 |
4,782 |
$288K |
| 0099U |
|
686 |
557 |
$285K |
| 70498 |
|
1,370 |
1,234 |
$284K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
4,396 |
4,026 |
$279K |
| 71250 |
|
3,016 |
2,838 |
$279K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
4,155 |
3,780 |
$277K |
| 96376 |
|
7,877 |
4,535 |
$274K |
| 86140 |
|
19,160 |
15,557 |
$274K |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
1,286 |
1,182 |
$274K |
| 93308 |
|
2,976 |
2,592 |
$273K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
3,675 |
3,445 |
$273K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
5,836 |
5,029 |
$271K |
| 84520 |
|
14,556 |
9,791 |
$268K |
| 82247 |
|
14,446 |
8,925 |
$265K |
| 36415 |
Collection of venous blood by venipuncture |
57,296 |
47,758 |
$263K |
| 20610 |
|
2,993 |
2,585 |
$262K |
| 80051 |
|
10,808 |
6,902 |
$259K |
| 77334 |
|
976 |
608 |
$255K |
| 87631 |
|
2,014 |
1,803 |
$253K |
| 82805 |
|
2,265 |
1,849 |
$250K |
| 96368 |
|
2,315 |
1,401 |
$243K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
18,861 |
17,054 |
$242K |
| 83615 |
|
15,658 |
9,141 |
$239K |
| 84439 |
|
10,590 |
9,593 |
$237K |
| J1644 |
Injection, heparin sodium, per 1000 units |
7,216 |
3,347 |
$236K |
| 88307 |
|
1,406 |
1,101 |
$236K |
| 83690 |
|
13,508 |
11,564 |
$225K |
| 93226 |
|
954 |
887 |
$222K |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
597 |
478 |
$221K |
| 84703 |
|
4,605 |
3,850 |
$216K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
9,843 |
9,352 |
$207K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,913 |
1,758 |
$205K |
| 93320 |
|
1,787 |
1,611 |
$205K |
| 84132 |
|
4,961 |
3,786 |
$203K |
| 82728 |
|
9,319 |
8,438 |
$196K |
| 77336 |
|
2,031 |
920 |
$193K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
603 |
566 |
$190K |
| 88185 |
|
1,715 |
1,526 |
$189K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
716 |
638 |
$189K |
| 88341 |
|
1,586 |
1,348 |
$188K |
| 83880 |
|
5,935 |
5,133 |
$184K |
| 76830 |
Ultrasound, transvaginal |
2,183 |
2,002 |
$184K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
591 |
559 |
$184K |
| 85652 |
|
12,910 |
11,225 |
$183K |
| 77300 |
|
585 |
447 |
$176K |
| 31575 |
|
1,964 |
1,832 |
$176K |
| 82330 |
|
4,190 |
3,528 |
$175K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
3,237 |
2,586 |
$174K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
2,732 |
1,025 |
$173K |
| 93271 |
|
781 |
726 |
$173K |
| 82607 |
|
7,374 |
6,860 |
$172K |
| 88342 |
|
3,062 |
2,606 |
$172K |
| G0379 |
Direct admission of patient for hospital observation care |
707 |
589 |
$172K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
5,395 |
3,354 |
$172K |
| 86003 |
|
2,351 |
1,958 |
$171K |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
1,107 |
806 |
$167K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
6,941 |
6,215 |
$167K |
| J9312 |
Injection, rituximab, 10 mg |
58 |
24 |
$167K |
| 87077 |
|
8,835 |
7,854 |
$167K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
6,235 |
1,995 |
$165K |
| J0185 |
Injection, aprepitant, 1 mg |
334 |
156 |
$164K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
776 |
692 |
$162K |
| 82310 |
|
11,044 |
6,996 |
$162K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
5,554 |
3,758 |
$161K |
| 87340 |
|
8,277 |
7,367 |
$160K |
| 84466 |
|
8,059 |
7,426 |
$158K |
| 88142 |
|
5,359 |
4,645 |
$157K |
| 87040 |
|
4,163 |
2,693 |
$155K |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
757 |
620 |
$154K |
| 86803 |
|
8,491 |
7,612 |
$152K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
1,322 |
1,238 |
$151K |
| 76942 |
|
1,093 |
938 |
$150K |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
2,236 |
2,023 |
$147K |
| 76642 |
|
2,147 |
1,740 |
$143K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
5,674 |
3,961 |
$143K |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
1,592 |
1,152 |
$142K |
| 80076 |
|
5,840 |
5,093 |
$142K |
| 77412 |
|
815 |
107 |
$142K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
3,973 |
1,562 |
$141K |
| 64494 |
|
834 |
650 |
$141K |
| 94060 |
|
1,990 |
1,888 |
$141K |
| 92133 |
|
3,825 |
3,639 |
$140K |
| 88304 |
|
1,920 |
1,630 |
$140K |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
1,546 |
1,251 |
$138K |
| 83540 |
|
9,018 |
8,304 |
$137K |
| 82570 |
|
10,161 |
8,698 |
$135K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,525 |
1,915 |
$131K |
| 70491 |
|
422 |
387 |
$130K |
| 95951 |
|
422 |
190 |
$129K |
| 62323 |
|
547 |
486 |
$128K |
| 76825 |
|
620 |
582 |
$127K |
| 73630 |
|
4,617 |
3,855 |
$127K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
3,623 |
3,393 |
$124K |
| 83970 |
|
3,927 |
3,430 |
$124K |
| 73564 |
|
4,108 |
3,267 |
$123K |
| 84295 |
|
3,412 |
2,553 |
$123K |
| 73610 |
|
4,143 |
3,520 |
$123K |
| J2785 |
Injection, regadenoson, 0.1 mg |
652 |
580 |
$120K |
| 87653 |
|
2,488 |
2,340 |
$117K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
3,296 |
2,946 |
$117K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
934 |
730 |
$115K |
| 82784 |
|
5,477 |
3,473 |
$115K |
| 87522 |
Neg quan hep c or qual rna |
2,099 |
1,876 |
$115K |
| J0475 |
Injection, baclofen, 10 mg |
172 |
152 |
$112K |
| 81002 |
|
11,345 |
9,662 |
$111K |
| 73110 |
|
2,957 |
2,416 |
$111K |
| 84156 |
|
5,919 |
5,124 |
$110K |
| 82947 |
|
2,577 |
2,247 |
$109K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
220 |
200 |
$109K |
| 82746 |
|
4,604 |
4,280 |
$108K |
| 70486 |
|
700 |
654 |
$107K |
| 17110 |
|
628 |
582 |
$107K |
| 76536 |
|
1,349 |
1,277 |
$107K |
| 95811 |
|
172 |
168 |
$106K |
| 82977 |
|
3,737 |
3,085 |
$105K |
| 92250 |
|
6,137 |
5,327 |
$105K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
540 |
457 |
$105K |
| 72110 |
|
2,598 |
2,357 |
$104K |
| 73130 |
|
2,792 |
2,314 |
$104K |
| 82550 |
|
5,258 |
4,102 |
$104K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
2,224 |
2,008 |
$103K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
1,876 |
1,114 |
$102K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,541 |
3,409 |
$102K |
| 87070 |
|
5,045 |
4,463 |
$102K |
| 72082 |
|
2,624 |
2,476 |
$102K |
| 87481 |
|
1,812 |
1,603 |
$101K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
1,129 |
1,033 |
$99K |
| 86592 |
|
4,796 |
4,249 |
$98K |
| 92082 |
|
4,357 |
4,103 |
$97K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
4,386 |
1,895 |
$96K |
| 73030 |
|
3,972 |
3,285 |
$95K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
6,355 |
5,807 |
$95K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
6,657 |
2,805 |
$95K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
7,381 |
6,062 |
$93K |
| 93321 |
|
697 |
650 |
$92K |
| 72170 |
|
2,183 |
1,898 |
$92K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
766 |
683 |
$92K |
| 82378 |
|
2,550 |
1,907 |
$91K |
| 82435 |
|
817 |
693 |
$91K |
| 76827 |
|
619 |
581 |
$90K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,678 |
1,350 |
$89K |
| 87186 |
|
6,529 |
5,750 |
$89K |
| 87210 |
|
4,532 |
4,070 |
$87K |
| 97161 |
|
1,479 |
1,241 |
$87K |
| 93971 |
|
1,577 |
1,422 |
$87K |
| 73590 |
|
2,855 |
2,379 |
$86K |
| 83516 |
|
3,840 |
2,727 |
$86K |
| 82040 |
|
8,475 |
5,457 |
$86K |
| 90715 |
|
3,265 |
2,977 |
$84K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
194 |
173 |
$84K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
311 |
259 |
$84K |
| 86762 |
|
4,233 |
3,676 |
$83K |
| J7298 |
Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg |
108 |
70 |
$83K |
| 93017 |
|
1,136 |
1,034 |
$83K |
| 87205 |
|
4,822 |
4,245 |
$82K |
| 93225 |
|
959 |
891 |
$82K |
| 80050 |
General health panel |
2,120 |
2,026 |
$81K |
| 77002 |
|
282 |
238 |
$80K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
2,508 |
1,994 |
$79K |
| 94729 |
|
1,985 |
1,916 |
$79K |
| 74018 |
|
2,414 |
2,031 |
$78K |
| 97162 |
|
1,924 |
1,637 |
$78K |
| 88313 |
|
827 |
683 |
$78K |
| 74178 |
|
360 |
331 |
$78K |
| 29075 |
|
449 |
394 |
$77K |
| 20553 |
|
510 |
471 |
$76K |
| 88184 |
|
1,787 |
1,572 |
$75K |
| 93970 |
|
771 |
681 |
$75K |
| 93304 |
|
250 |
231 |
$75K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
2,095 |
1,799 |
$74K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
746 |
679 |
$72K |
| 95886 |
|
1,076 |
1,030 |
$71K |
| 93270 |
|
781 |
726 |
$70K |
| 73552 |
|
2,632 |
2,234 |
$69K |
| 76801 |
|
911 |
807 |
$69K |
| 73090 |
|
1,818 |
1,484 |
$69K |
| 86923 |
|
1,189 |
878 |
$69K |
| 81025 |
|
2,310 |
2,005 |
$67K |
| 94726 |
|
1,643 |
1,584 |
$67K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
1,811 |
1,605 |
$66K |
| C1893 |
Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, other than peel-away |
406 |
306 |
$65K |
| 87081 |
|
4,589 |
4,292 |
$65K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
828 |
714 |
$65K |
| 86706 |
|
3,305 |
3,056 |
$65K |
| 73080 |
|
1,933 |
1,641 |
$64K |
| 86480 |
|
1,222 |
1,146 |
$62K |
| 90686 |
|
4,618 |
4,068 |
$62K |
| 80069 |
|
3,046 |
2,393 |
$62K |
| 77066 |
Tomosynthesis, mammo |
560 |
521 |
$61K |
| 77065 |
Tomosynthesis, mammo |
1,018 |
942 |
$60K |
| 85379 |
|
2,034 |
1,815 |
$58K |
| 96377 |
|
624 |
385 |
$57K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
3,206 |
3,006 |
$57K |
| 97166 |
|
1,508 |
1,282 |
$56K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
2,357 |
1,398 |
$56K |
| 86704 |
|
2,374 |
2,163 |
$56K |
| 95715 |
|
155 |
94 |
$55K |
| 64635 |
|
146 |
82 |
$55K |
| 86038 |
|
2,182 |
2,025 |
$55K |
| 82105 |
|
1,732 |
1,538 |
$54K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
522 |
426 |
$54K |
| 73522 |
|
1,629 |
1,548 |
$53K |
| C1760 |
Closure device, vascular (implantable/insertable) |
206 |
183 |
$53K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
4,512 |
2,413 |
$52K |
| 97165 |
|
869 |
724 |
$52K |
| 92567 |
|
3,690 |
3,467 |
$52K |
| 72040 |
|
1,849 |
1,653 |
$51K |
| 74019 |
|
1,983 |
1,815 |
$51K |
| 59025 |
Fetal non-stress test |
1,379 |
826 |
$51K |
| 90732 |
|
759 |
682 |
$51K |
| 90670 |
|
2,200 |
2,034 |
$50K |
| 73562 |
|
1,423 |
1,128 |
$50K |
| 86255 |
|
1,453 |
1,315 |
$50K |
| 73560 |
|
2,103 |
1,731 |
$50K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
874 |
703 |
$49K |
| 94010 |
|
2,068 |
1,813 |
$49K |
| 84481 |
|
1,305 |
1,154 |
$49K |
| 84550 |
|
3,254 |
2,619 |
$48K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
906 |
863 |
$48K |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
2,202 |
1,976 |
$48K |
| 72050 |
|
993 |
941 |
$47K |
| 87536 |
|
563 |
541 |
$47K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
743 |
682 |
$47K |
| 11102 |
|
364 |
310 |
$47K |
| 92557 |
|
1,510 |
1,411 |
$46K |
| C9257 |
Injection, bevacizumab, 0.25 mg |
1,704 |
1,350 |
$46K |
| J3471 |
Injection, hyaluronidase, ovine, preservative free, per 1 usp unit (up to 999 usp units) |
210 |
155 |
$46K |
| 90658 |
|
2,542 |
2,315 |
$45K |
| 82140 |
|
1,789 |
1,503 |
$45K |
| 81513 |
|
936 |
875 |
$45K |
| 82785 |
|
1,863 |
1,695 |
$45K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
986 |
822 |
$45K |
| J1720 |
Injection, hydrocortisone sodium succinate, up to 100 mg |
1,159 |
878 |
$44K |
| 73502 |
|
1,868 |
1,619 |
$44K |
| 85018 |
|
3,249 |
2,584 |
$43K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,108 |
2,606 |
$43K |
| 93296 |
|
4,424 |
4,252 |
$42K |
| 86235 |
|
737 |
650 |
$42K |
| 96411 |
|
595 |
350 |
$41K |
| 96401 |
|
205 |
96 |
$40K |
| 11100 |
|
323 |
311 |
$40K |
| 88112 |
|
895 |
732 |
$39K |
| 93880 |
|
613 |
573 |
$39K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
2,256 |
1,121 |
$39K |
| 70250 |
|
257 |
224 |
$39K |
| 95911 |
|
274 |
258 |
$39K |
| J9045 |
Injection, carboplatin, 50 mg |
523 |
265 |
$39K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,477 |
1,687 |
$39K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
550 |
526 |
$39K |
| 96402 |
|
408 |
353 |
$38K |
| 84146 |
|
1,189 |
1,071 |
$38K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,451 |
1,295 |
$38K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
2,864 |
2,184 |
$38K |
| 90651 |
|
644 |
613 |
$38K |
| 82657 |
|
375 |
280 |
$38K |
| 0064U |
|
1,073 |
928 |
$37K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
606 |
523 |
$37K |
| 95700 |
|
316 |
300 |
$37K |
| 82043 |
|
3,827 |
3,532 |
$37K |
| 77295 |
|
127 |
81 |
$37K |
| 72100 |
|
1,467 |
1,306 |
$36K |
| 75574 |
|
217 |
206 |
$36K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
841 |
784 |
$36K |
| J7307 |
Etonogestrel (contraceptive) implant system, including implant and supplies |
31 |
16 |
$36K |
| 73140 |
|
718 |
600 |
$35K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
1,489 |
810 |
$35K |
| 87486 |
|
371 |
320 |
$35K |
| 87581 |
|
370 |
319 |
$35K |
| 90750 |
|
352 |
334 |
$35K |
| 74174 |
|
335 |
303 |
$34K |
| 83520 |
|
988 |
905 |
$34K |
| 80055 |
|
870 |
803 |
$33K |
| 83001 |
|
978 |
867 |
$32K |
| 89051 |
|
916 |
743 |
$32K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
782 |
623 |
$31K |
| J3490 |
Unclassified drugs |
11,335 |
2,851 |
$31K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
777 |
668 |
$31K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
365 |
306 |
$31K |
| 93923 |
|
824 |
781 |
$31K |
| 94664 |
|
569 |
458 |
$30K |
| 95885 |
|
469 |
441 |
$30K |
| 31231 |
|
294 |
279 |
$30K |
| 86300 |
|
1,501 |
1,306 |
$30K |
| 88173 |
|
247 |
192 |
$30K |
| 73060 |
|
1,144 |
957 |
$30K |
| 51798 |
|
1,810 |
1,691 |
$29K |
| 82533 |
|
660 |
536 |
$29K |
| J1453 |
Injection, fosaprepitant, 1 mg |
922 |
618 |
$29K |
| 86790 |
|
1,456 |
1,325 |
$29K |
| J8501 |
Aprepitant, oral, 5 mg |
476 |
359 |
$28K |
| 74230 |
|
291 |
270 |
$28K |
| 88360 |
|
184 |
139 |
$28K |
| 92611 |
|
214 |
197 |
$28K |
| 77080 |
|
503 |
486 |
$28K |
| J0744 |
Injection, ciprofloxacin for intravenous infusion, 200 mg |
121 |
108 |
$28K |
| 86618 |
|
1,347 |
900 |
$28K |
| 36592 |
|
727 |
578 |
$27K |
| 87902 |
|
146 |
122 |
$27K |
| 86160 |
|
734 |
688 |
$27K |
| C1874 |
Stent, coated/covered, with delivery system |
12 |
12 |
$27K |
| 82950 |
|
2,908 |
2,719 |
$27K |
| 76882 |
|
646 |
565 |
$27K |
| 95806 |
|
448 |
418 |
$26K |
| 95874 |
|
337 |
286 |
$26K |
| 36561 |
|
32 |
25 |
$25K |
| V2632 |
Posterior chamber intraocular lens |
539 |
464 |
$25K |
| 80197 |
|
2,451 |
1,017 |
$25K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
516 |
421 |
$24K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
184 |
141 |
$24K |
| 95910 |
|
294 |
274 |
$24K |
| 86780 |
|
2,744 |
2,556 |
$24K |
| 85046 |
|
1,808 |
1,582 |
$24K |
| 82670 |
|
587 |
540 |
$24K |
| 83883 |
|
674 |
584 |
$23K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
338 |
312 |
$23K |
| 84403 |
|
872 |
803 |
$23K |
| 72072 |
|
642 |
586 |
$23K |
| 87147 |
|
826 |
769 |
$22K |
| J2060 |
Injection, lorazepam, 2 mg |
1,273 |
944 |
$22K |
| 84165 |
|
1,225 |
1,094 |
$22K |
| 87015 |
|
756 |
622 |
$22K |
| 99201 |
|
1,499 |
1,294 |
$22K |
| 76813 |
|
357 |
320 |
$22K |
| J2704 |
Injection, propofol, 10 mg |
13,599 |
11,151 |
$22K |
| 86334 |
|
545 |
483 |
$22K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
635 |
576 |
$21K |
| 52000 |
|
115 |
106 |
$21K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
2,035 |
855 |
$21K |
| 62369 |
|
200 |
192 |
$21K |
| 86376 |
|
775 |
710 |
$21K |
| 80164 |
|
1,279 |
1,129 |
$20K |
| 99495 |
|
478 |
456 |
$20K |
| 86431 |
|
1,090 |
1,000 |
$20K |
| J2506 |
Injection, pegfilgrastim, excludes biosimilar, 0.5 mg |
64 |
50 |
$20K |
| 96112 |
|
238 |
207 |
$20K |
| 93925 |
|
316 |
298 |
$20K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
367 |
364 |
$20K |
| 11104 |
|
136 |
102 |
$20K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
500 |
467 |
$20K |
| 72131 |
|
143 |
132 |
$20K |
| 90671 |
|
381 |
364 |
$20K |
| 74022 |
|
368 |
328 |
$19K |
| 95819 |
|
87 |
77 |
$19K |
| 36591 |
|
1,977 |
1,505 |
$19K |
| 77387 |
|
95 |
12 |
$19K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
295 |
284 |
$19K |
| 76937 |
|
449 |
388 |
$19K |
| 29425 |
|
137 |
118 |
$19K |
| 92587 |
|
726 |
671 |
$18K |
| 0065U |
|
2,381 |
2,192 |
$18K |
| Q9960 |
High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml |
214 |
177 |
$18K |
| 77001 |
|
224 |
185 |
$18K |
| 58300 |
|
136 |
108 |
$18K |
| 10060 |
|
182 |
165 |
$18K |
| 86200 |
|
791 |
725 |
$17K |
| 83655 |
|
1,237 |
1,161 |
$17K |
| 87075 |
|
439 |
368 |
$17K |
| 88312 |
|
209 |
178 |
$17K |
| 73501 |
|
671 |
623 |
$17K |
| 87799 |
|
472 |
280 |
$17K |
| 87102 |
|
620 |
503 |
$17K |
| 84153 |
|
1,011 |
950 |
$17K |
| 64642 |
|
103 |
85 |
$17K |
| 88275 |
|
36 |
25 |
$16K |
| 64483 |
|
62 |
55 |
$16K |
| 51600 |
|
63 |
57 |
$16K |
| 84155 |
|
1,775 |
1,391 |
$16K |
| 64490 |
|
32 |
28 |
$16K |
| 92579 |
|
536 |
504 |
$16K |
| 64491 |
|
32 |
28 |
$16K |
| 94762 |
|
161 |
108 |
$16K |
| J9070 |
Cyclophosphamide, 100 mg |
37 |
12 |
$15K |
| 86147 |
|
233 |
204 |
$15K |
| 95115 |
|
1,829 |
1,107 |
$15K |
| 73100 |
|
316 |
225 |
$15K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
772 |
705 |
$15K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
285 |
249 |
$15K |
| 73700 |
|
147 |
129 |
$15K |
| 20611 |
|
148 |
125 |
$15K |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
550 |
224 |
$15K |
| 92504 |
|
804 |
758 |
$14K |
| 87184 |
|
846 |
764 |
$14K |
| 84425 |
|
703 |
656 |
$14K |
| 86317 |
|
953 |
707 |
$14K |
| 86304 |
|
571 |
480 |
$14K |
| 87324 |
|
536 |
499 |
$14K |
| 96132 |
|
457 |
400 |
$14K |
| 86870 |
|
430 |
333 |
$14K |
| 78999 |
|
130 |
97 |
$14K |
| 71271 |
|
337 |
325 |
$14K |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
86 |
68 |
$13K |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
87 |
68 |
$13K |
| 81514 |
|
175 |
121 |
$13K |
| J3300 |
Injection, triamcinolone acetonide, preservative free, 1 mg |
18 |
12 |
$13K |
| G0008 |
Administration of influenza virus vaccine |
639 |
597 |
$13K |
| 88311 |
|
418 |
325 |
$13K |
| 77280 |
|
36 |
24 |
$13K |
| 83002 |
|
400 |
368 |
$13K |
| 84145 |
|
807 |
544 |
$13K |
| 90791 |
Psychiatric diagnostic evaluation |
372 |
352 |
$13K |
| 64636 |
|
79 |
32 |
$13K |
| 82150 |
|
491 |
422 |
$13K |
| Q4038 |
Cast supplies, short leg cast, adult (11 years +), fiberglass |
172 |
140 |
$12K |
| 85049 |
|
678 |
415 |
$12K |
| 88271 |
|
36 |
25 |
$12K |
| J2997 |
Injection, alteplase recombinant, 1 mg |
92 |
62 |
$11K |
| 81015 |
|
352 |
325 |
$11K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
186 |
134 |
$11K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
456 |
415 |
$11K |
| J3480 |
Injection, potassium chloride, per 2 meq |
784 |
389 |
$11K |
| G8989 |
Self care functional limitation, discharge status, at discharge from therapy or to end reporting |
62 |
52 |
$11K |
| 77072 |
|
364 |
349 |
$11K |
| 87181 |
|
394 |
365 |
$11K |
| 81003 |
|
419 |
366 |
$11K |
| 86146 |
|
126 |
106 |
$11K |
| G0297 |
Low dose ct scan (ldct) for lung cancer screening |
96 |
90 |
$11K |
| J1569 |
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg |
12 |
12 |
$10K |
| C1729 |
Catheter, drainage |
254 |
172 |
$10K |
| J1940 |
Injection, furosemide, up to 20 mg |
679 |
463 |
$10K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
180 |
175 |
$10K |
| 87497 |
|
338 |
168 |
$10K |
| 84590 |
|
749 |
713 |
$10K |
| 82172 |
|
215 |
191 |
$10K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
135 |
130 |
$10K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,270 |
1,177 |
$10K |
| 77470 |
|
31 |
27 |
$10K |
| 83010 |
|
229 |
201 |
$10K |
| 82374 |
|
14 |
12 |
$10K |
| 86709 |
|
554 |
491 |
$10K |
| 82390 |
|
309 |
299 |
$10K |
| 74220 |
|
113 |
100 |
$9K |
| 95117 |
|
646 |
300 |
$9K |
| 74455 |
|
45 |
40 |
$9K |
| 86920 |
|
266 |
179 |
$9K |
| 92136 |
|
580 |
557 |
$9K |
| 83721 |
|
555 |
487 |
$9K |
| 69210 |
|
55 |
53 |
$8K |
| A9541 |
Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries |
28 |
27 |
$8K |
| 12001 |
|
87 |
76 |
$8K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
67 |
60 |
$8K |
| 82103 |
|
373 |
359 |
$8K |
| 85613 |
|
123 |
104 |
$8K |
| 72190 |
|
188 |
168 |
$8K |
| 64405 |
|
32 |
12 |
$8K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
300 |
259 |
$8K |
| 78264 |
|
39 |
38 |
$8K |
| 86665 |
|
341 |
194 |
$7K |
| 84402 |
|
399 |
368 |
$7K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
368 |
354 |
$7K |
| 83525 |
|
325 |
307 |
$7K |
| 93298 |
|
535 |
511 |
$7K |
| 82010 |
|
487 |
423 |
$7K |
| 86301 |
|
224 |
180 |
$7K |
| 77073 |
|
211 |
177 |
$7K |
| 87209 |
|
160 |
152 |
$7K |
| J3473 |
Injection, hyaluronidase, recombinant, 1 usp unit |
260 |
218 |
$7K |
| 86833 |
|
31 |
28 |
$7K |
| 80175 |
|
275 |
256 |
$7K |
| 94618 |
|
33 |
28 |
$7K |
| 76870 |
|
80 |
68 |
$6K |
| 86832 |
|
30 |
27 |
$6K |
| 29125 |
|
41 |
40 |
$6K |
| 86364 |
|
613 |
574 |
$6K |
| 76820 |
|
346 |
168 |
$6K |
| 87177 |
|
160 |
152 |
$6K |
| 82542 |
|
169 |
154 |
$6K |
| 73070 |
|
172 |
135 |
$6K |
| 78832 |
|
20 |
17 |
$6K |
| 17000 |
|
52 |
40 |
$6K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
89 |
88 |
$6K |
| 84446 |
|
175 |
163 |
$6K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,433 |
1,348 |
$6K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
186 |
174 |
$6K |
| 87045 |
|
136 |
127 |
$6K |
| 88237 |
|
17 |
13 |
$6K |
| 92020 |
|
396 |
368 |
$6K |
| 80177 |
|
500 |
462 |
$6K |
| 76775 |
|
104 |
96 |
$6K |
| 88264 |
|
16 |
12 |
$6K |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
428 |
295 |
$6K |
| 90474 |
|
723 |
665 |
$6K |
| 82232 |
|
303 |
266 |
$6K |
| 81508 |
|
88 |
79 |
$6K |
| 70480 |
|
43 |
42 |
$6K |
| 87046 |
|
136 |
127 |
$5K |
| 80143 |
|
473 |
425 |
$5K |
| J1815 |
Injection, insulin, per 5 units |
1,306 |
521 |
$5K |
| J1630 |
Injection, haloperidol, up to 5 mg |
242 |
195 |
$5K |
| 74221 |
|
19 |
12 |
$5K |
| 77370 |
|
15 |
12 |
$5K |
| 84157 |
|
193 |
158 |
$5K |
| 90832 |
Psychotherapy, 30 minutes with patient |
113 |
95 |
$5K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
252 |
242 |
$5K |
| 93799 |
|
1,004 |
951 |
$5K |
| 90636 |
|
67 |
62 |
$5K |
| 99215 |
Prolong outpt/office vis |
228 |
200 |
$5K |
| 92285 |
|
106 |
99 |
$5K |
| 74183 |
|
66 |
65 |
$4K |
| 86696 |
|
250 |
238 |
$4K |
| 93288 |
|
306 |
297 |
$4K |
| 80179 |
|
390 |
356 |
$4K |
| 51728 |
|
47 |
40 |
$4K |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
146 |
104 |
$4K |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
146 |
104 |
$4K |
| 83930 |
|
83 |
72 |
$4K |
| 84300 |
|
213 |
178 |
$4K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
94 |
71 |
$4K |
| 77061 |
|
335 |
329 |
$4K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
91 |
84 |
$4K |
| 90648 |
|
2,202 |
2,053 |
$4K |
| 90723 |
|
1,587 |
1,495 |
$4K |
| 86308 |
|
77 |
70 |
$4K |
| 87529 |
|
82 |
72 |
$4K |
| 93458 |
|
26 |
26 |
$4K |
| 95971 |
|
83 |
79 |
$4K |
| 0097U |
|
72 |
66 |
$4K |
| 90734 |
|
431 |
398 |
$4K |
| 83521 |
|
245 |
227 |
$3K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
42 |
40 |
$3K |
| J9267 |
Injection, paclitaxel, 1 mg |
83 |
40 |
$3K |
| 91320 |
|
133 |
128 |
$3K |
| 86664 |
|
211 |
194 |
$3K |
| 99490 |
Ccm add 20min |
659 |
632 |
$3K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
1,281 |
1,116 |
$3K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
164 |
159 |
$3K |
| 83835 |
|
28 |
25 |
$3K |
| 86800 |
|
101 |
87 |
$3K |
| 87427 |
|
129 |
117 |
$3K |
| 86695 |
|
250 |
238 |
$3K |
| 82787 |
|
209 |
189 |
$3K |
| 90680 |
|
1,110 |
1,020 |
$3K |
| 87329 |
|
25 |
25 |
$3K |
| 87328 |
|
25 |
25 |
$3K |
| Q4010 |
Cast supplies, short arm cast, adult (11 years +), fiberglass |
27 |
24 |
$3K |
| 12011 |
|
40 |
40 |
$3K |
| J9370 |
Vincristine sulfate, 1 mg |
239 |
143 |
$3K |
| 0001A |
|
129 |
121 |
$3K |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
92 |
52 |
$3K |
| 96156 |
|
64 |
62 |
$3K |
| 83519 |
|
32 |
26 |
$3K |
| 82139 |
|
95 |
90 |
$3K |
| J7609 |
Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg |
26 |
20 |
$3K |
| 73523 |
|
46 |
43 |
$3K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
107 |
51 |
$3K |
| 83921 |
|
121 |
112 |
$3K |
| 86617 |
|
140 |
105 |
$3K |
| 90633 |
|
917 |
860 |
$3K |
| 73000 |
|
113 |
99 |
$3K |
| 84305 |
|
86 |
85 |
$3K |
| 83935 |
|
63 |
58 |
$2K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
101 |
93 |
$2K |
| 87116 |
|
75 |
66 |
$2K |
| 77290 |
|
15 |
14 |
$2K |
| 0124A |
|
207 |
194 |
$2K |
| 0002A |
|
100 |
86 |
$2K |
| 80074 |
|
49 |
49 |
$2K |
| 78830 |
|
28 |
24 |
$2K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,843 |
1,246 |
$2K |
| 82525 |
|
121 |
116 |
$2K |
| 88720 |
|
244 |
184 |
$2K |
| 96133 |
|
161 |
156 |
$2K |
| 49083 |
|
24 |
12 |
$2K |
| 76981 |
|
30 |
26 |
$2K |
| 99205 |
Prolong outpt/office vis |
96 |
93 |
$2K |
| 93289 |
|
97 |
91 |
$2K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
14 |
13 |
$2K |
| 93922 |
|
37 |
37 |
$2K |
| 78306 |
|
22 |
17 |
$2K |
| 92015 |
Determination of refractive state |
903 |
864 |
$2K |
| 11730 |
|
13 |
12 |
$2K |
| 29065 |
|
17 |
13 |
$2K |
| 84445 |
|
28 |
25 |
$2K |
| 93242 |
|
363 |
344 |
$2K |
| 82340 |
|
52 |
44 |
$2K |
| 90707 |
|
288 |
268 |
$2K |
| 72141 |
|
43 |
43 |
$2K |
| 86141 |
|
114 |
108 |
$2K |
| A6204 |
Composite dressing, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing |
48 |
37 |
$2K |
| 86644 |
|
77 |
66 |
$2K |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
58 |
41 |
$2K |
| 82164 |
|
86 |
72 |
$2K |
| 86774 |
|
158 |
139 |
$2K |
| 88300 |
|
113 |
96 |
$2K |
| 90716 |
|
244 |
234 |
$2K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
9,030 |
7,041 |
$2K |
| 73120 |
|
40 |
40 |
$2K |
| 86787 |
|
107 |
92 |
$2K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
276 |
233 |
$2K |
| 95909 |
|
40 |
38 |
$2K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
3,160 |
1,734 |
$1K |
| 70030 |
|
48 |
40 |
$1K |
| 84134 |
|
136 |
118 |
$1K |
| 97535 |
Self-care/home management training, each 15 minutes |
439 |
220 |
$1K |
| 81596 |
|
17 |
12 |
$1K |
| 83021 |
|
13 |
12 |
$1K |
| 85384 |
|
42 |
36 |
$1K |
| 77003 |
|
16 |
12 |
$1K |
| 58301 |
|
14 |
14 |
$1K |
| 12002 |
|
12 |
12 |
$1K |
| 87206 |
|
72 |
64 |
$1K |
| 99173 |
|
175 |
172 |
$1K |
| 80178 |
|
153 |
135 |
$1K |
| 93299 |
|
70 |
67 |
$1K |
| 0004A |
|
123 |
96 |
$1K |
| 86645 |
|
82 |
77 |
$1K |
| 88230 |
|
15 |
13 |
$1K |
| 95970 |
|
14 |
13 |
$1K |
| 92551 |
|
127 |
127 |
$1K |
| 99406 |
|
69 |
65 |
$1K |
| 90480 |
|
192 |
186 |
$1K |
| 90656 |
|
370 |
354 |
$1K |
| 84166 |
|
13 |
13 |
$1K |
| 64643 |
|
16 |
13 |
$1K |
| 90700 |
|
290 |
273 |
$994.38 |
| Q0177 |
Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
698 |
412 |
$986.22 |
| 80081 |
|
15 |
14 |
$943.18 |
| 99443 |
|
44 |
44 |
$938.60 |
| 99487 |
Ccm add 20min |
168 |
163 |
$926.53 |
| 0054A |
|
70 |
64 |
$923.19 |
| 84630 |
|
100 |
93 |
$903.72 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
244 |
221 |
$889.26 |
| 88302 |
|
45 |
41 |
$867.29 |
| 99496 |
|
13 |
13 |
$859.16 |
| 84207 |
|
41 |
39 |
$855.10 |
| 83993 |
|
57 |
50 |
$844.26 |
| 82945 |
|
115 |
92 |
$839.46 |
| 43235 |
|
12 |
12 |
$837.00 |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
132 |
68 |
$836.25 |
| 83986 |
|
14 |
14 |
$834.18 |
| 72156 |
|
26 |
24 |
$826.92 |
| 90657 |
|
152 |
145 |
$822.66 |
| 96127 |
|
322 |
304 |
$821.24 |
| 90694 |
|
228 |
224 |
$811.57 |
| 86769 |
|
15 |
15 |
$802.35 |
| 82962 |
|
642 |
603 |
$784.64 |
| 92555 |
|
40 |
39 |
$774.03 |
| 76885 |
|
18 |
14 |
$751.33 |
| 51705 |
|
12 |
12 |
$749.63 |
| J9000 |
Injection, doxorubicin hydrochloride, 10 mg |
31 |
12 |
$747.26 |
| 11721 |
|
12 |
12 |
$742.84 |
| 82017 |
|
13 |
12 |
$713.59 |
| 72128 |
|
13 |
13 |
$637.42 |
| 93312 |
|
13 |
13 |
$631.06 |
| 89230 |
|
13 |
13 |
$564.92 |
| 99441 |
|
57 |
57 |
$546.84 |
| 10005 |
|
17 |
12 |
$533.06 |
| 90662 |
|
27 |
18 |
$530.65 |
| 86812 |
|
26 |
24 |
$494.48 |
| 99442 |
|
46 |
46 |
$490.00 |
| Q9961 |
High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml |
93 |
80 |
$489.87 |
| 86922 |
|
18 |
13 |
$464.15 |
| 86705 |
|
45 |
43 |
$448.17 |
| 90746 |
|
12 |
12 |
$443.33 |
| 93246 |
|
80 |
79 |
$437.26 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
142 |
79 |
$412.94 |
| P9603 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled |
3,066 |
2,240 |
$383.96 |
| 92610 |
|
13 |
12 |
$382.78 |
| 82627 |
|
19 |
16 |
$372.35 |
| 83090 |
|
13 |
12 |
$347.90 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
863 |
460 |
$344.40 |
| 90834 |
Psychotherapy, 45 minutes with patient |
12 |
12 |
$325.60 |
| 97803 |
|
12 |
12 |
$323.48 |
| 80306 |
|
30 |
28 |
$307.43 |
| 86039 |
|
30 |
28 |
$303.51 |
| 83498 |
|
12 |
12 |
$302.42 |
| 80202 |
|
24 |
12 |
$293.92 |
| 36416 |
|
63 |
56 |
$293.67 |
| 76604 |
|
13 |
12 |
$278.44 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
257 |
219 |
$270.20 |
| 99024 |
|
41 |
35 |
$268.09 |
| 82085 |
|
29 |
26 |
$258.99 |
| 84270 |
|
16 |
16 |
$257.13 |
| Q9963 |
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
1,087 |
888 |
$252.06 |
| 76512 |
|
27 |
24 |
$243.80 |
| 87338 |
|
18 |
15 |
$232.36 |
| A9561 |
Technetium tc-99m oxidronate, diagnostic, per study dose, up to 30 millicuries |
21 |
16 |
$232.10 |
| Q2038 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) |
168 |
156 |
$231.57 |
| 74420 |
|
12 |
12 |
$229.83 |
| 92025 |
|
30 |
27 |
$228.79 |
| 72081 |
|
14 |
13 |
$222.58 |
| 90710 |
|
73 |
70 |
$201.79 |
| 86316 |
|
12 |
12 |
$200.09 |
| 96416 |
|
21 |
12 |
$192.65 |
| 99177 |
|
75 |
74 |
$182.55 |
| 90696 |
|
53 |
52 |
$181.94 |
| 93243 |
|
20 |
16 |
$164.66 |
| 90655 |
|
51 |
43 |
$164.08 |
| 90653 |
|
45 |
45 |
$151.63 |
| C1726 |
Catheter, balloon dilatation, non-vascular |
181 |
152 |
$151.40 |
| 80047 |
|
17 |
12 |
$148.32 |
| 97804 |
|
54 |
54 |
$140.79 |
| 83020 |
|
13 |
12 |
$133.88 |
| 85306 |
|
14 |
12 |
$130.77 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
91 |
84 |
$125.73 |
| 0134A |
|
16 |
15 |
$123.68 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
25 |
25 |
$120.61 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
1,195 |
981 |
$114.70 |
| A4648 |
Tissue marker, implantable, any type, each |
66 |
55 |
$113.98 |
| 96040 |
|
16 |
12 |
$99.81 |
| 87088 |
|
14 |
14 |
$98.92 |
| 86849 |
|
12 |
12 |
$98.72 |
| 80156 |
|
14 |
12 |
$95.94 |
| 82365 |
|
16 |
14 |
$95.76 |
| 83695 |
|
12 |
12 |
$81.06 |
| G1010 |
Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program |
1,995 |
1,654 |
$73.87 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
294 |
242 |
$67.33 |
| 84436 |
|
16 |
14 |
$55.62 |
| J9190 |
Injection, fluorouracil, 500 mg |
18 |
12 |
$50.47 |
| 99152 |
|
116 |
112 |
$43.19 |
| 85347 |
|
12 |
12 |
$41.25 |
| 94760 |
|
41 |
29 |
$40.30 |
| 96139 |
|
67 |
62 |
$35.46 |
| 96138 |
|
69 |
64 |
$34.69 |
| A9573 |
Injection, gadopiclenol, 1 ml |
386 |
376 |
$30.54 |
| 99153 |
Mod sedat endo service >5yrs |
75 |
71 |
$24.59 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
26 |
24 |
$20.65 |
| 91312 |
|
31 |
31 |
$19.24 |
| C1889 |
Implantable/insertable device, not otherwise classified |
58 |
55 |
$15.47 |
| V2788 |
Presbyopia correcting function of intraocular lens |
16 |
13 |
$7.76 |
| 93356 |
|
123 |
117 |
$6.50 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
77 |
58 |
$4.50 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
16 |
16 |
$4.08 |
| 91300 |
|
127 |
102 |
$0.00 |
| 80360 |
|
13 |
13 |
$0.00 |
| 80355 |
|
70 |
67 |
$0.00 |
| A4649 |
Surgical supply; miscellaneous |
30 |
29 |
$0.00 |
| 80323 |
|
14 |
13 |
$0.00 |
| P9045 |
Infusion, albumin (human), 5%, 250 ml |
12 |
12 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
29 |
26 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
264 |
244 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
14 |
13 |
$0.00 |
| 80349 |
|
15 |
12 |
$0.00 |
| 91305 |
|
17 |
17 |
$0.00 |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
32 |
24 |
$0.00 |